secwatch.observer — SEC 8-K summary
======================================

Issuer:     Research Solutions, Inc. (RSSS)
CIK:        0001386301
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0001104659-23-017587
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Research Solutions Q2 FY23 revenue up 10.7% to $8.7M; platform rev +31%, ARR $8.8M
--------------------------------------------------------------------------------

- Total revenue $8.7M (+10.7% YoY); platform rev $2.1M (+31%); transaction rev $6.6M (+5.4%).
- Gross margin +300bps to 39.0%; net loss narrows to ($0.01)/shr from ($0.02)/shr.
- Adjusted EBITDA positive at $201K vs -$165K; operating cash flow $0.9M for the quarter.
- ARR up 28% to $8.8M; added 34 net platform deployments, ending at 790 deployments.
- New Curedatis offering launched in Q2; management confident in long-term platform growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386301/000110465923017587/0001104659-23-017587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386301/000110465923017587/tm236092d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-017587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer